The Phase 3 SENTRY trial (XPORT-MF-034; NCT04562389) completed enrollment with 353 patients ... to be in the range of $110 million to $120 million. Lowering the range of R&D and selling, general and ...

Management reiterated full-year 2025 guidance for total revenue of $140 million to $155 million and U.S. XPOVIO net product revenue of $110 million to $120 million. Macomber updated, "We are lowering ...

Chevron Corporation (NYSE: CVX) reported earnings of $3.5 billion ($1.82 per share - diluted) for third quarter 2025, compared with $4.5 billion ($2.48 per share - diluted) in third quarter 2024.

Ladies and gentlemen, welcome to The Navigator Company conference call and webcast for the third quarter and 9 months results. Joining us today are the following directors: Antonio Redondo, Fernando ...

Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the third quarter ended September 30, 2025 and ...

Read Lenskart Solutions IPO Review and Analysis on The Economic Times. Find out Lenskart Solutions IPO Issue Price, Subscription Dates and Status, Lenskart Solutions IPO Listing Date and more.

After the pandemic, works by young, unproven artists flew off dealers’ walls onto the auction block, where these pieces set records. Slotin Auction has been the go-to auction house for folk art, ...

Trump Mulls More Aid to Argentina as Government Shutdown Continues SNAP funding is about to expire thanks to the government shutdown, leaving millions of Americans hungry. But Donald Trump still wants ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.